![Eric Lachenmeier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Lachenmeier is Vice President of Corporate Development for Complete Genomics, Inc. Previously, he was Vice President of Technology Development for Applied Biosystems (NASDAQ: ABI) and Incyte Genomics (NASDAQ: INCY).
Mr. Lachenmeier has 20 years of experience in technology and biotechnology with both venture-funded startups and public companies.
He received a BS degree in Mechanical Engineering from the Massachusetts Institute of Technology (MIT) and an MBA from the Wharton School of Business.
| Companies | Position | End |
|---|---|---|
Applied Biosystems, Inc.
 Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Manufactures genomics and proteomics related research instruments | Corporate Officer/Principal | - |
| INCYTE CORPORATION | Corporate Officer/Principal | - |
| COMPLETE GENOMICS, INC. | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 5 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Complete Genomics, Inc.
 Complete Genomics, Inc. BiotechnologyHealth Technology Develops and markets DNA sequencing technology | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Applied Biosystems, Inc.
Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Manufactures genomics and proteomics related research instruments | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
